Purdue Pharma, known for its controversial painkiller OxyContin, is on the brink of dissolution following a judge's ruling on May 1, 2026.
During the hearing, emotional testimonies were shared by families affected by addiction, including mothers mourning their lost sons and individuals who have struggled with addiction.
This ruling represents a pivotal moment in the ongoing efforts to address the opioid crisis, reflecting the deep impact of addiction on communities.